Related Experiment Videos
Macrophages in human tumours: an immunohistochemical study
The Journal of Pathology
|February 1, 1982
Summary
Lysozyme staining identified specific macrophages in human tumors, particularly in colonic and gastric sites. However, non-specific esterase and acid phosphatase stained tumor cells, limiting their diagnostic utility.
Area of Science:
- Oncology
- Immunohistochemistry
- Histopathology
Background:
- Macrophages play a role in tumor microenvironments.
- Accurate identification of macrophage populations is crucial for understanding tumor behavior and developing targeted therapies.
- Histochemical and immunohistochemical methods are used to characterize cellular components within tumors.
Purpose of the Study:
- To evaluate the utility of non-specific esterase (NSE), acid phosphatase (AP), and lysozyme staining in identifying macrophages within human tumors.
- To compare the specificity and sensitivity of these staining methods in various tumor types.
- To assess the presence and distribution of lysozyme-positive macrophages (LPM) in malignant and benign lesions.
Main Methods:
- Histochemical staining for non-specific esterase (NSE) and acid phosphatase (AP).
- Immunohistochemical staining for lysozyme.
- Analysis of 45 human malignant tumors and 3 benign lesions.
Main Results:
- Lysozyme staining detected specific macrophages (LPM), with higher numbers observed in colonic tumors and intralesional LPM in gastric and duodenal tumors.
- Squamous and mesenchymal tumors showed no significant LPM.
- AP and NSE stained both macrophages and tumor cells, reducing their specificity in certain tumor invasion contexts. Neutrophils were also stained but distinguishable by nuclear morphology.
Conclusions:
- Lysozyme is a specific marker for a subset of macrophages in tumors, offering valuable insights into tumor-associated immune responses.
- Non-specific esterase and acid phosphatase are less specific due to cross-reactivity with tumor cells, limiting their use in stromal invasion scenarios.
- The distribution of LPM varies by tumor type, suggesting site-specific roles for these immune cells in human neoplasms.